With the funds from 3D printing industry veterans Andy Christensen and Joe Allison, the company plans to expand additive manufacturing of medical parts and engineering services. ... Read more »
The cultivate(MD) Capital Fund II of Genesis Innovation Group made an investment in Genesis Software Innovations (GSI), developer of software solutions that will initially focus on the orthopedic space. ... Read more »
The company was awarded a €2.5 million grant, received a U.S. patent and entered into a new technology license agreement. ... Read more »
New funding, expected to close at $22MM, will support growth of its regenerative medicine MSC manufacturing platform worldwide. ... Read more »
Fusion Robotics closed a financing round with lead investment by Alex Lukianov of Lukpartners, LLC and Kevin Foley, M.D. Proceeds will help ready the company's spinal robotics platform to obtain regulatory clearance and begin commercialization. ... Read more »
Funding 2019 has driven research & development and regulatory activity for companies working to get their first product on the market and those seeking to expand globally. Familiar names like Intrinsic Therapeutics and Graftys, as well as new companies like HAPPE Spine and Magnesium Develop... Read more »
Orthopedic pediatric care gained recognition with a funding pitch competition that granted five winners $50,000 to support commercialization.... Read more »
The virtual reality-based platform is using Small Business Innovation Research Program support to add automation to its surgical assessment tool.... Read more »
Investors who spoke during October's Musculoskeletal New Ventures Conference (MNVC) pointed to extremities, sports medicine, digital health and the hospital supply chain as areas that remain particularly attractive for innovation.... Read more »
The private equity firm is focused exclusively on musculoskeletal healthcare.... Read more »
We looked at funding, patent and trial/study announcements from January 2017 to June 2018 to see whose initiatives are making waves; many of these companies offer technologies that could make them acquisition or collaboration targets for large OEMs.... Read more »
The b-ONE™ cementless total hip system is the company’s first product following a US $20.0MM round of Series A financing.... Read more »
Orthopaedic professionals can expect to hear about technologies being commercialized by 22 companies along with insight from long-term investors during the conference, held October 23-24 in Memphis, Tennessee.... Read more »
These funding announcements feature technologies related to each of the market segments: spine, trauma, arthroscopy/soft tissue, joint reconstruction and orthobiologics.... Read more »
The company is addressing the issue of wear debris and seeks capital to collect data on sub-assembly components of its Tendonoid™ Web Joint technology.... Read more »
Within the second half of 2017, we’ve noticed a jump in announcements pertaining to what we call “surgical assistance” tools: platforms designed to improve ease of use, support a personalized implant fit for patients, etc. Here’s what’s been making the headlines.... Read more »
Funding announcements that we tracked from orthopaedic companies in 1H17 included eight arthroscopy/soft tissue-related technologies we’d like to highlight because of their novelty and early-stage backing.... Read more »
Medin Technologies continues to manufacture sterilization cases and trays for the orthopaedic industry. ... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
